- Home
- ALT vs PSTL Comparison
ALT vs PSTL Comparison
Compare ALT & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- PSTL
- Stock Information
- Founded
- ALT 1997
- PSTL 2018
- Country
- ALT United States
- PSTL United States
- Employees
- ALT N/A
- PSTL N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- PSTL Real Estate Investment Trusts
- Sector
- ALT Health Care
- PSTL Real Estate
- Exchange
- ALT Nasdaq
- PSTL Nasdaq
- Market Cap
- ALT 292.0M
- PSTL 329.8M
- IPO Year
- ALT N/A
- PSTL 2019
- Fundamental
- Price
- ALT $3.83
- PSTL $15.84
- Analyst Decision
- ALT Strong Buy
- PSTL Strong Buy
- Analyst Count
- ALT 6
- PSTL 1
- Target Price
- ALT $17.40
- PSTL $17.75
- AVG Volume (30 Days)
- ALT 3.0M
- PSTL 149.9K
- Earning Date
- ALT 08-12-2025
- PSTL 08-04-2025
- Dividend Yield
- ALT N/A
- PSTL 6.12%
- EPS Growth
- ALT N/A
- PSTL 344.13
- EPS
- ALT N/A
- PSTL 0.39
- Revenue
- ALT $20,000.00
- PSTL $86,535,000.00
- Revenue This Year
- ALT N/A
- PSTL $22.00
- Revenue Next Year
- ALT $761,880.20
- PSTL $9.76
- P/E Ratio
- ALT N/A
- PSTL $40.92
- Revenue Growth
- ALT N/A
- PSTL 26.43
- 52 Week Low
- ALT $2.90
- PSTL $12.26
- 52 Week High
- ALT $11.16
- PSTL $15.84
- Technical
- Relative Strength Index (RSI)
- ALT 51.79
- PSTL 70.89
- Support Level
- ALT $3.35
- PSTL $15.31
- Resistance Level
- ALT $3.66
- PSTL $15.55
- Average True Range (ATR)
- ALT 0.19
- PSTL 0.24
- MACD
- ALT 0.07
- PSTL 0.11
- Stochastic Oscillator
- ALT 86.18
- PSTL 100.00
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.